Apellis Pharmaceuticals, Inc. (DELISTED) (APLS:DL)
41.03
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
Apellis Pharmaceuticals Total Assets (Quarterly) : 1.083B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 29.48B |
| Eli Lilly & Co. | 116.58B |
| Agios Pharmaceuticals, Inc. | 1.185B |
| Spyre Therapeutics, Inc. | 763.95M |
| Scholar Rock Holding Corp. | 535.25M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 667.61M |
| Shareholders Equity (Quarterly) | 414.92M |
| Debt to Equity Ratio | 1.147 |
| Current Ratio | 3.627 |
| Net Debt Paydown Yield | -0.02% |